Free  Moderate use of medicines

Marketing Authorisations

Ceftazidime + avibactam (Zavicefta°) in infants and children

Anidulafungin (Ecalta°) in invasive candidiasis in children

Adalimumab (Humira°) in ulcerative colitis in children from 6 years of age

Dolutegravir (Tivicay°) as 5 mg dispersible tablets for HIV from 4 weeks of age

Imiquimod 3.75% cream (Zyclara°) in actinic keratosis

Editors' opinion. Misleading

Meningococcal B vaccine containing lipoproteins fHbp A and B (Trumenba°)

Clopidogrel added to aspirin to prevent recurrence of ischaemic stroke

Ponesimod (Ponvory°) in multiple sclerosis

Nitisinone (Orfadin°) in alkaptonuria in adults: may only improve laboratory results

Adverse Effects

Mycophenolic acid and pregnancy: genotoxicity, malformations, spontaneous abortions

Inset. How long should one wait after stopping a drug before starting a pregnancy?

Common stem: cef-

Free  Rituximab: late-onset neutropenia, sometimes more than 6 months after stopping treatment (continued)

Immune checkpoint inhibitors: cardiovascular disorders

Clozapine: danger from sudden reintroduction

Outlook

Free  Annual review of drug packaging: choose high-quality packaging for safer health care

Free  Queries and Comments: EMA's response to Prescrire's analysis of EMA's transparency policy over the last 10 years

The European Implementing Regulation on Pharmacovigilance Activities

Masthead

Free  Masthead